{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:31:18Z","timestamp":1792513878169,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.radonc.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:46:38Z","timestamp":1657280798000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study"],"prefix":"10.1016","volume":"175","author":[{"given":"Huageng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.07.006_b0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2022.07.006_b0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.oraloncology.2019.01.005","article-title":"Reprint of Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy","volume":"90","author":"Miao","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-014-0326-z","article-title":"Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"10","author":"Zheng","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/408514","article-title":"Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.radonc.2022.07.006_b0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/bjc.2013.720","article-title":"Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors","volume":"110","author":"Zeng","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0030","first-page":"1","article-title":"Clinical study of 139 nasopharyngeal carcinoma patients for intensity-modulated radiation therapy","volume":"15","author":"Zhao","year":"2006","journal-title":"Chinese J Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2014.05.005","article-title":"Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study","volume":"112","author":"Wu","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0045","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","article-title":"Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial","volume":"66","author":"Pow","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1053-4296(03)00033-X","article-title":"How should we measure and report radiotherapy-induced xerostomia?","volume":"13","author":"Eisbruch","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21147\/j.issn.1000-9604.2018.03.03","article-title":"Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial","volume":"30","author":"Chang","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.radonc.2022.07.006_b0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1368-8375(98)00016-5","article-title":"The use of pilocarpine hydrochloride to prevent xerostomia in a child treated with high dose radiotherapy for nasopharynx carcinoma","volume":"34","author":"Deutsch","year":"1998","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hed.21461","article-title":"Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-Year outcomes","volume":"33","author":"Liu","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2022.07.006_b0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0360-3016(99)00247-3","article-title":"Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer","volume":"45","author":"Eisbruch","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0075","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(00)01441-3","article-title":"A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results","volume":"49","author":"Chao","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cncr.29795","article-title":"Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy: Staging of Nasopharyngeal Cancer","volume":"122","author":"Pan","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0085","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience","volume":"60","author":"Kam","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2019.05.023","article-title":"Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity-modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis","volume":"138","author":"Sommat","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0095","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/cncr.20552","article-title":"Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function","volume":"101","author":"Kwong","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijrobp.2006.04.033","article-title":"Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy","volume":"66","author":"Hsiung","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0105","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/cncr.25754","article-title":"Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study","volume":"117","author":"Xiao","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jicru_ndq002","article-title":"International Commission on Radiation Units and Measurements; Prescribing recording and reporting photon-beam intensity-modulated Radiation Therapy (IMRT). ICRU Report","volume":"10","author":"ICRU","year":"2010","journal-title":"J ICRU"},{"key":"10.1016\/j.radonc.2022.07.006_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4441","article-title":"Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer","volume":"7","author":"van Luijk","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.radonc.2022.07.006_b0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3747\/co.20.1485","article-title":"Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"20","author":"Zhang","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2020.03.029","article-title":"A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal Carcinoma","volume":"107","author":"Miao","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0140","first-page":"925","article-title":"Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients","volume":"23","author":"Pellegrino","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0145","first-page":"847","article-title":"Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients","volume":"25","author":"Memtsa","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0150","first-page":"566","article-title":"Reliability and validity of Chinese version of Xerostomia Questionnaire in nasopharyngeal carcinoma patients undergoing radiotherapy","volume":"28","author":"Wang","year":"2019","journal-title":"Chinese J Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0155","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.07.006_b0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clon.2007.10.006","article-title":"A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma","volume":"20","author":"Chau","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2022.07.006_b0165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/bjc.2014.553","article-title":"A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes","volume":"112","author":"Miah","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2022.07.006_b0170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2004.12.076","article-title":"Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy","volume":"62","author":"Blanco","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0175","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.07.006_b0180","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijrobp.2006.09.021","article-title":"The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy","volume":"67","author":"Li","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022041913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:21Z","timestamp":1759123281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022041913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":36,"alternative-id":["S0167814022041913"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.07.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}